Skip to content

Effect of Transcranial Direct Current Stimulation on Postoperative Pain in Patients Undergoing Radical Resection for Colon Cancer and Rectal Cancer with Preoperative Sleep Disturbance: A Prospective, Randomized, Double-Blind, Controlled Study

Effect of Transcranial Direct Current Stimulation on Postoperative Pain in Patients Undergoing Radical Resection for Colon Cancer and Rectal Cancer with Preoperative Sleep Disturbance: A Prospective, Randomized, Double-Blind, Controlled Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110411
Enrollment
Unknown
Registered
2025-10-13
Start date
2025-10-13
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Intervention group (tDCS group): Patients received 2 mA tDCS for 20 minutes. The current rose for 30 seconds at the beginning and then dropped for 30 seconds at the end.
Control group (sham tDCS group)::At the start of each treatment session, patients only received a 30-second current rise and a 30-second current drop, with no constant 2 mA stimulation for the remaini

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The enrolled subjects must meet all of the following conditions: 1 Patients scheduled for elective "laparoscopic radical resection of colon or rectal cancer" under general anesthesia; 2 Age >= 18 years; 3 ASA classification I-III; 4 Clear consciousness and ability to act; 5 Preoperative sleep disorder: Pittsburgh Sleep Quality Index (PSQI) score >= 7 points

Exclusion criteria

Exclusion criteria: 1 Hearing impairment, unable to complete the test as required; 2 Individuals with a history of central nervous system diseases who have developed language or intellectual impairments; 3 Those with contraindications for tDCS (such as skull defects or skin injuries); 4 Patients with metal or electronic implants in the brain or nearby areas: such as brain pacemakers, cerebral vascular clips, cardiac pacemakers, etc.; 5 History of epilepsy, skin damage, severe heart, lung, kidney, or liver diseases, pregnancy, or history of drug abuse (including alcohol use); 6 Chronic pain syndromes, long-term use of opioid drugs or sedatives (>3 months); 7 Severe mental disorders (such as depression, schizophrenia); 8 Unable to understand sleep and pain scores and unable to cooperate with the research; 9 BMI 35 kg/m2; 10 Allergic or contraindicated to opioid drugs, non-steroidal anti-inflammatory drugs (NSAIDs), or antiemetic drugs.

Design outcomes

Primary

MeasureTime frame
The incidence of moderate to severe pain in patients within 24 hours after the operation (defined as a Numerical Rating Scale NRS score of 4 or higher).;

Secondary

MeasureTime frame
The first postoperative analgesic administration was administered at a time immediately following the completion of the surgery.;The cumulative number of times of remedial analgesia used within 24 hours, 48 hours and 72 hours after the operation.;Sleep quality the night before the surgery and the first night after the surgery;The occurrence of nausea and vomiting within 24 hours, 48 hours, and 72 hours after the operation (mild, moderate, severe);Postoperative 72-hour recovery quality and satisfaction with pain relief;The number of days spent in hospital after the surgery and the proportion of patients with fever;The incidence and duration of new shoulder pain, lower limb pain or numbness that occurred after the surgery;The incidence of subacute pain, sleep quality and all-cause mortality 30 days after the surgery;The incidence of chronic pain on the 90th day after the surgery;The incidence rates of moderate to severe pain in patients within 48 hours and 72 hours after the operation;

Countries

China

Contacts

Public ContactShi Jing

Affiliated Hospital of Guizhou Medical University

315585290@qq.com+86 186 8503 4016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026